A new target ligand Ser–Glu for PEPT1-overexpressing cancer imaging

Tongcheng Dai1 State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, People’s Republic of China

Na Li1 State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, People’s Republic of China

Lingzhi Zhang1 State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, People’s Republic of China

Yuanxing Zhang1 State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, People’s Republic of China;2 Shanghai Collaborative Innovation Center for Biomanufacturing Technology, Shanghai, People’s Republic of China

Qin Liu1 State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, People’s Republic of China;2 Shanghai Collaborative Innovation Center for Biomanufacturing Technology, Shanghai, People’s Republic of ChinaCorrespondence[email protected]

Pages 203-212 | Published online: 11 Jan 2016

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

WangAZLangerRFarokhzadOCNanoparticle delivery of cancer drugsAnnu Rev Med20126318519821888516
PubMed Web of Science ®Google Scholar
FerrariMCancer nanotechnology: opportunities and challengesNat Rev Cancer20055316117115738981
PubMed Web of Science ®Google Scholar
ShaoZShaoJTanBTargeted lung cancer therapy: preparation and optimization of transferrin-decorated nanostructured lipid carriers as novel nanomedicine for co-delivery of anticancer drugs and DNAInt J Nanomed2015101223
PubMed Web of Science ®Google Scholar
PrabhuRHPatravaleVBJoshiMDPolymeric nanoparticles for targeted treatment in oncology: current insightsInt J Nanomed2015101001
PubMed Web of Science ®Google Scholar
MaedaHThe link between infection and cancer: tumor vasculature, free radicals, and drug delivery to tumors via the EPR effectCancer Sci2013104777978923495730
PubMed Web of Science ®Google Scholar
ChenHZhenZToddTChuPKXieJNanoparticles for improving cancer diagnosisMater Sci Eng Reports2013743356924068857
PubMed Web of Science ®Google Scholar
NobleGTStefanickJFAshleyJDKiziltepeTBilgicerBLigand-targeted liposome design: challenges and fundamental considerationsTrends Biotechnol2014321324524210498
PubMed Web of Science ®Google Scholar
HuMZhangKThe application of aptamers in cancer research: an up-to-date reviewFuture Oncol20139336937623469972
PubMed Web of Science ®Google Scholar
KirpotinDBDrummondDCShaoYAntibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal modelsCancer Res200666136732674016818648
PubMed Web of Science ®Google Scholar
ChoiCHJAlabiCAWebsterPDavisMEMechanism of active targeting in solid tumors with transferrin-containing gold nanoparticlesProc Natl Acad Sci201010731235124020080552
PubMed Web of Science ®Google Scholar
XiaoYLinZTChenYHigh molecular weight chitosan derivative polymeric micelles encapsulating superparamagnetic iron oxide for tumor-targeted magnetic resonance imagingInt J Nanomed2015101155
PubMed Web of Science ®Google Scholar
LiuY-RGuanY-YLuanXDelta-like ligand 4-targeted nanomedicine for antiangiogenic cancer therapyBiomaterials20154216117125542804
PubMed Web of Science ®Google Scholar
GianellaAJarzynaPAManiVMultifunctional nanoemulsion platform for imaging guided therapy evaluated in experimental cancerACS Nano2011564422443321557611
PubMed Web of Science ®Google Scholar
ChattopadhyayNFongeHCaiZRole of antibody-mediated tumor targeting and route of administration in nanoparticle tumor accumulation in vivoMol Pharm2012982168217922734589
PubMed Web of Science ®Google Scholar
ProkopiouERyderSAWalshJTumour vasculature targeting agents in hybrid/conjugate drugsAngiogenesis201316350352423543223
PubMed Web of Science ®Google Scholar
BertrandNWuJXuXKamalyNFarokhzadOCCancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biologyAdv Drug Deliv Rev20146622524270007
PubMed Web of Science ®Google Scholar
KamalyNXiaoZValenciaPMRadovic-MorenoAFFarokhzadOCTargeted polymeric therapeutic nanoparticles: design, development and clinical translationChemical Soc Rev201241729713010
PubMed Web of Science ®Google Scholar
ChenZDengJZhaoYTaoTCyclic RGD peptide-modified liposomal drug delivery system: enhanced cellular uptake in vitro and improved pharmacokinetics in ratsInt J Nanomed201273803
PubMed Web of Science ®Google Scholar
MitsuokaKMiyoshiSKatoYCancer detection using a PET tracer, 11C-glycylsarcosine, targeted to H+/peptide transporterJ Nucl Med200849461562218344442
PubMed Web of Science ®Google Scholar
Herrera-RuizDKnippGTCurrent perspectives on established and putative mammalian oligopeptide transportersJ Pharm Sci200392469171412661057
PubMed Web of Science ®Google Scholar
BockmanDEGanapathyVOblakTGLeibachFHLocalization of peptide transporter in nuclei and lysosomes of the pancreasInt J Pancreatol19972232212259444554
PubMedGoogle Scholar
GonzalezDECovitzK-MYSadéeWMrsnyRJAn oligopeptide transporter is expressed at high levels in the pancreatic carcinoma cell lines AsPc-1 and Capan-2Cancer Res19985835195259458100
PubMed Web of Science ®Google Scholar
MitsuokaKKatoYMiyoshiSInhibition of oligopeptide transporter suppress growth of human pancreatic cancer cellsEur J Pharm Sci201040320220820307658
PubMed Web of Science ®Google Scholar
LandowskiCPVigBSSongXAmidonGLTargeted delivery to PEPT1-overexpressing cells: acidic, basic, and secondary floxuridine amino acid ester prodrugsMol Cancer Therap20054465966715827340
PubMed Web of Science ®Google Scholar
ZhangLZhangLLuoTZhouJSunLXuYSynthesis and Evaluation of a Dipeptide–Drug Conjugate Library As Substrates for PEPT1ACS Combinat Sci2012142108114
Web of Science ®Google Scholar
XiongLShuhendlerAJRaoJSelf-luminescing BRET-FRET near-infrared dots for in vivo lymph-node mapping and tumour imagingNature Commun20123119323149738
PubMed Web of Science ®Google Scholar
SchmittgenTDLivakKJAnalyzing real-time PCR data by the comparative CT methodNature Protocols2008361101110818546601
PubMed Web of Science ®Google Scholar
PoirierABelliSFunkCRole of the intestinal peptide transporter PEPT1 in oseltamivir absorption: in vitro and in vivo studiesDrug Metab Disposit201240815561565
Web of Science ®Google Scholar
LuoGYuXJinCLyP-1-conjugated nanoparticles for targeting drug delivery to lymphatic metastatic tumorsInt J Pharmaceut20103851150156
PubMed Web of Science ®Google Scholar
NamgungRLeeYMKimJPoly-cyclodextrin and poly-paclitaxel nano-assembly for anticancer therapyNature Commun20145
Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

A new target ligand Ser–Glu for PEPT1-overexpressing cancer imaging

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

A new target ligand Ser–Glu for PEPT1-overexpressing cancer imaging

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date